LTA.sub.4 , hydrolase inhibitors
US5925654A · kind A · utility
2Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 1997 |
| Grant date | Jul 20, 1999 |
| Priority date | — |
| Expiry date | Mar 12, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D277/24
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds having the structure: ##STR1## and pharmaceutically acceptable salts and stereoisomers thereof that are useful in the treatment of inflammatory diseases which are mediated by LTB.sub.4 production, such as psoriasis, ulcerative colitis, IBD, and asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.